State of Tennessee, Department of Treasury’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

State of Tennessee, Department of Treasury’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-52,895	Closed	-$201K	–	1655
2020 Q1	$201K	Sell	52,895 -1,645	-3%	-$7.09K	﹤0.01%	1363
2019 Q4	$278K	Sell	54,540 -5,960	-10%	-$31.5K	﹤0.01%	1405
2019 Q3	$306K	Buy	60,500 +5,487	+10%	+$27.4K	﹤0.01%	1395
2019 Q2	$339K	Buy	55,013 +2,527	+5%	+$12.2K	﹤0.01%	1321
2019 Q1	$244K	Sell	52,486 -605	-1%	-$2.74K	﹤0.01%	1407
2018 Q4	$223K	Sell	53,091 -178	-0.3%	-$906	﹤0.01%	1401
2018 Q3	$334K	Buy	53,269 +4,685	+10%	+$36K	﹤0.01%	1386
2018 Q2	$391K	Sell	48,584 -1,698	-3%	-$13K	﹤0.01%	1377
2018 Q1	$375K	Sell	50,282 -5,280	-10%	-$35.1K	﹤0.01%	1364
2017 Q4	$331K	Sell	55,562 -6,049	-10%	-$36.8K	﹤0.01%	1428
2017 Q3	$453K	Sell	61,611 -3,894	-6%	-$24.7K	﹤0.01%	1347
2017 Q2	$445K	Hold	65,505	–	–	﹤0.01%	1379
2017 Q1	$618K	Buy	+65,505	New	+$654K	﹤0.01%	1307

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.9B AUM 39.77% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $51.1B AUM 35.55% 1-Year Est. Return

State of Tennessee, Department of Treasury's PGNX Position: Q2 2020 in Review

State of Tennessee, Department of Treasury sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 52,895 shares — an estimated $201K sold.

State of Tennessee, Department of Treasury first reported a position in PGNX in Q1 2017 and held it in 13 quarters. The position peaked at $618K in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

State of Tennessee, Department of Treasury reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
State of Tennessee, Department of Treasury sold 52,895 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $201K.
State of Tennessee, Department of Treasury first reported a position in Progenics Pharmaceuticals Inc in Q1 2017 and held it in 13 quarters.
State of Tennessee, Department of Treasury's Progenics Pharmaceuticals Inc position peaked at $618K in Q1 2017.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on State of Tennessee, Department of Treasury's 13F filing for Q2 2020, filed 13 Aug 2020.